Cita APA

Contreras, C. M., Akbay, E. A., Gallardo, T. D., Haynie, J. M., Sharma, S., Tagao, O., . . . Castrillon, D. H. (2010). Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy. The Company of Biologists Limited.

Citación estilo Chicago

Contreras, Cristina M., et al. Lkb1 Inactivation Is Sufficient to Drive Endometrial Cancers That Are Aggressive yet Highly Responsive to MTOR Inhibitor Monotherapy. The Company of Biologists Limited, 2010.

Cita MLA

Contreras, Cristina M., et al. Lkb1 Inactivation Is Sufficient to Drive Endometrial Cancers That Are Aggressive yet Highly Responsive to MTOR Inhibitor Monotherapy. The Company of Biologists Limited, 2010.